Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections

Penetration of Ertapenem into Muscle Measured by In Vivo Microdialysis in Mechanically Ventilated Patients

(2011) I. Boyadjiev et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and bacteriological survey of diabetic foot infections in Lisbon

(2011) J.J. Mendes et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections

(2011) R.A. Seaton et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

(2010) Marta Ulldemolins et al.   CLINICAL PHARMACOKINETICS

Current medical management of diabetic foot infections

(2010) Mark A Kosinski et al.   Expert Review of Anti-Infective Therapy

Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations

(2009) Olaf Burkhardt et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

(2008) A.J. Brink et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock?

(2007) Robert Sauermann et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS